Conferences

← vista completa

Published on February 1, 2010 | http://doi.org/10.5867/medwave.2010.02.4405

Diagnosis and management of supraventricular tachycardias: flutter and atrial fibrillation

Diagnóstico y manejo de las taquicardias supraventriculares: flutter y fibrilación auricular

René Asenjo

This work is licensed under a Creative Commons Attribution 4.0 International License. Esta licencia permite el uso, distribución y reproducción del artículo en cualquier medio, siempre y cuando se otorgue el crédito correspondiente al autor del artículo y al medio en que se publica, en este caso, Medwave.

Authors

René Asenjo

Hospital Clínico Universidad de Chile, Santiago, Chile

Figures

Article has no figures.

Forum

No messages

History

Citation Asenjo R. Diagnosis and management of supraventricular tachycardias: flutter and atrial fibrillation. Medwave 2010;10(2):e4405 doi: 10.5867/medwave.2010.02.4405

Submission date 01/01/1970

Acceptance date 01/01/1970

Publication date 01/02/2010

Index

Metrics

Not available at the moment.

Notes

References

  1. McNamara RL, Brass LM, Drozda JP Jr, Go AS, Halperin JL, Kerr CR, et al. ACC/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Data Standards on Atrial Fibrillation). Circulation. 2004 Jun 29;109(25):3223-43. | CrossRef | PubMed
  2. Asenjo R. Intervalo QT prolongado: un factor de riesgo de muerte súbita frecuentemente olvidado. Rev Chil Cardiol 2009; 28: 397-400 | Link
  3. Singer DE, Albers GW, Dalen JE, Go AS, Halperin JL, Manning WJ. Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004 Sep;126(3 Suppl):429S-456S. | PubMed
  4. Fuster V, Rydén LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation): developed in Collaboration With the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol. 2001 Oct;38(4):1231-66. | CrossRef | PubMed
  5. Wachtell K, Lehto M, Gerdts E, Olsen MH, Hornestam B, Dahlöf B, et al. Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. J Am Coll Cardiol. 2005 Mar 1;45(5):712-9. | CrossRef | PubMed